Trial Outcomes & Findings for Study to Compare Survival for ASTRA TECH Implant System, OsseoSpeed™ Implants Following Immediate Loading in Extraction Sockets Versus Immediate Loading in Healed Ridges (NCT NCT00710944)

NCT ID: NCT00710944

Last Updated: 2014-07-11

Results Overview

An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

132 participants

Primary outcome timeframe

12 months after implant placement

Results posted on

2014-07-11

Participant Flow

Participant milestones

Participant milestones
Measure
Extraction Sockets
Immediate loading of implants placed in extraction sockets. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Healed Ridges
Immediate loading of implants placed in healed ridges. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Grafted Sites
Immediate loading of implants placed in grafted sites (four months healing after grafting). OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Overall Study
STARTED
55
58
19
Overall Study
COMPLETED
45
49
17
Overall Study
NOT COMPLETED
10
9
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study to Compare Survival for ASTRA TECH Implant System, OsseoSpeed™ Implants Following Immediate Loading in Extraction Sockets Versus Immediate Loading in Healed Ridges

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Extraction Sockets
n=55 Participants
Immediate loading of implants placed in extraction sockets. ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Healed Ridges
n=58 Participants
Immediate loading of implants placed in healed ridges. ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Grafted Sites
n=19 Participants
Immediate loading of implants placed in grafted sites (four months healing after grafting). ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Total
n=132 Participants
Total of all reporting groups
Age, Continuous
45 years
STANDARD_DEVIATION 14 • n=5 Participants
42 years
STANDARD_DEVIATION 15 • n=7 Participants
40 years
STANDARD_DEVIATION 17 • n=5 Participants
42 years
STANDARD_DEVIATION 17 • n=4 Participants
Sex: Female, Male
Female
33 Participants
n=5 Participants
33 Participants
n=7 Participants
7 Participants
n=5 Participants
73 Participants
n=4 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
25 Participants
n=7 Participants
12 Participants
n=5 Participants
59 Participants
n=4 Participants

PRIMARY outcome

Timeframe: 12 months after implant placement

Population: Per protocol analysis presented, this includes implants immediately loaded (Group A: 55 implants in 55 subjects, Group B: 58 implants in 58 subjects, Group C: 19 implants in 19 subjects), of these 5 implants in total failed within 12 months after implant placement.

An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Outcome measures

Outcome measures
Measure
Extraction Sockets
n=55 Implants
Immediate loading of implants placed in extraction sockets. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Healed Ridges
n=58 Implants
Immediate loading of implants placed in healed ridges. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Grafted Sites
n=19 Implants
Immediate loading of implants placed in grafted sites (four months healing after grafting). OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Implant Survival
94.55 percentage of implants
98.28 percentage of implants
94.73 percentage of implants

Adverse Events

Extractions Sockets

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Healed Ridges

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Grafted Sites

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Extractions Sockets
n=55 participants at risk
Immediate loading of implants placed in extraction sockets. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Healed Ridges
n=58 participants at risk
Immediate loading of implants placed in healed ridges. OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Grafted Sites
n=19 participants at risk
Immediate loading of implants placed in grafted sites (four months healing after grafting). OsseoSpeed™: OsseoSpeed™ Microthread™ Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
Reproductive system and breast disorders
Prostate cancer
1.8%
1/55
0.00%
0/58
0.00%
0/19
Respiratory, thoracic and mediastinal disorders
Lung cancer
0.00%
0/55
1.7%
1/58
0.00%
0/19
Gastrointestinal disorders
Stomach cancer
0.00%
0/55
1.7%
1/58
0.00%
0/19
Blood and lymphatic system disorders
Acute lymphangitis
1.8%
1/55
0.00%
0/58
0.00%
0/19

Other adverse events

Adverse event data not reported

Additional Information

Senior Manager Global Clinical Research

DENTSPLY Implants

Phone: +46313763500

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60